Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
IFSO Global Registry studied more than 1 lakh bariatric surgeries over 18 countries and has reported a mortality of 0.03%
Contact us with your distribution plan for a custom quote
Variability in Patient Responses The variability is influenced by factors such as genetics, metabolism, and lifestyle
Pricing predictability: No membership fees, no consultation fees, no dose escalation surcharges, no promotional pricing that expires
Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes management and now licensed for chronic weight management in adults with obesity or overweight with weight-related comorbidities
US$ 26.47
US$ 29.14
US$ 25.34
US$ 27.53
US$ 22.51
US$ 21.25
US$ 27.83
US$ 21.69
